Tenderwize
Wróć do wyszukiwania

Open House Drug Discount Contracts for the Active Ingredient Ibuprofen, ATC M01AE01

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 217 days left·Open·Supplies
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Ibuprofen, ATC M01AE01

80/100

Ocena szansy

PromisingLow complexity
SuppliesOpen
Skąd ta ocena?

Szansa

80 / 100

Złożoność

20 / 100

Czynniki ryzyka

The buyer reserves the right to replace open-house contracts with exclusive discount contracts via EU-wide tender at an...

Structured data flags EU funding (isEuFunded: true), but the XML notice explicitly states 'no-eu-funds'. This inconsist...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Strong opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Conclusion of non-exclusive discount contracts for Ibuprofen (ATC M01AE01) drugs under SGB V.
  • Open house model: all interested pharmaceutical companies can join without selection.
Pokaż pełne podsumowanie

The AOK Rheinland-Pfalz/Saarland offers non-exclusive drug discount contracts (Open House) for the active ingredient Ibuprofen (ATC M01AE01) under German social law (SGB V). All pharmaceutical companies with authorized and marketable Ibuprofen products in Germany can join without selection. Contracts have a maximum duration of 24 months, starting from June 2025. The notice is published voluntarily and does not constitute an EU procurement. Paper-based submission is required; electronic submission is not allowed. The tender has no estimated value and no specific award criteria. Note: The structured data indicates EU funding, but the XML notice explicitly states no EU funding. This analysis is based on the structured data and XML notice only; no separate procurement documents were analyzed.

Ryzyka

The buyer reserves the right to replace open-house contracts with exclusive discount contracts via EU-wide tender at an...

Structured data flags EU funding (isEuFunded: true), but the XML notice explicitly states 'no-eu-funds'. This inconsist...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Eligibility

  • Only authorized and marketable drugs in Germany (proof via Lauer-Taxe listing or AMIce database) are eligible.

Administrative

  • Paper-based submission required; electronic submission is not allowed.
  • Submission in German language only (as per notice language).

Kryteria udzielenia

Lot 1

No award criteria; this is an open-house model with no selection.

Zamawiający

Lokalizacja

Eisenberg, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE271900642

Działalność

Health

Części (1)

LOT-0001

Open House Drug Discount Contracts for the Active Ingredient Ibuprofen, ATC M01AE01

Non-exclusive discount contracts for Ibuprofen drugs under German SGB V. Open to all pharmaceutical companies with authorized and marketable Ibuprofen products. Contracts last up to 24 months, with enrollment possible at the start of each month. All contracts end simultaneously 24 months after the earliest contract start date (June 2025). The buyer may replace open-house contracts with exclusive contracts via tender at any time.

SuppliesEU fundedElectronic submission

Lokalizacja

Eisenberg, Germany

Czas trwania

May 2025 - May 2027

Kategoria

Pharmaceutical products

Kryteria udzielenia

No award criteria; this is an open-house model with no selection.

Termin

Deadline Mar 31, 2027

Szczegóły zamówienia

Data publikacji
10 Apr 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
238514-2025

Dokumenty (1)

Podobne przetargi